<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="article-commentary" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC10330105</article-id>
        <article-id pub-id-type="pmcid-ver">PMC10330105.1</article-id>
        <article-id pub-id-type="pmcaid">10330105</article-id>
        <article-id pub-id-type="pmcaiid">10330105</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1881288</article-id>
        <article-id pub-id-type="pmid">36862133</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-22-3247</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1881288</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1881288</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Overcoming barriers to tumor genomic profiling through direct- to- patient outreach</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Doe-Tetteh</surname>
              <given-names initials="SA">Seyram A.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Camp</surname>
              <given-names initials="SY">Sabrina Y.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Reales</surname>
              <given-names initials="D">Dalicia</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Crowdis</surname>
              <given-names initials="J">Jett</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Noronha</surname>
              <given-names initials="AM">Anne Marie</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wolff</surname>
              <given-names initials="B">Bernadette</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Alano</surname>
              <given-names initials="T">Tina</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Galle</surname>
              <given-names initials="J">Jesse</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Duygu Selcuklu</surname>
              <given-names initials="S">S.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Viale</surname>
              <given-names initials="A">Agnes</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Socci</surname>
              <given-names initials="ND">Nicholas D.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names initials="YL">Ying L.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tew</surname>
              <given-names initials="WP">William P.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Aghajanian</surname>
              <given-names initials="C">Carol</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ladanyi</surname>
              <given-names initials="M">Marc</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>He</surname>
              <given-names initials="MX">Meng Xiao</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A17" ref-type="aff">17</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>AlDubayan</surname>
              <given-names initials="SH">Saud H.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A16" ref-type="aff">16</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mazor</surname>
              <given-names initials="RD">Roei David</given-names>
            </name>
            <xref rid="A11" ref-type="aff">11</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shpilberg</surname>
              <given-names initials="O">Ofer</given-names>
            </name>
            <xref rid="A11" ref-type="aff">11</xref>
            <xref rid="A12" ref-type="aff">12</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hershkovitz-Rokah</surname>
              <given-names initials="O">Oshrat</given-names>
            </name>
            <xref rid="A13" ref-type="aff">13</xref>
            <xref rid="A14" ref-type="aff">14</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Riancho</surname>
              <given-names initials="JA">Jose A.</given-names>
            </name>
            <xref rid="A18" ref-type="aff">18</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hernandez</surname>
              <given-names initials="JL">Jose L.</given-names>
            </name>
            <xref rid="A18" ref-type="aff">18</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gonzalez-Vela</surname>
              <given-names initials="MC">M. Carmen</given-names>
            </name>
            <xref rid="A19" ref-type="aff">19</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Buthorn</surname>
              <given-names initials="JJ">Justin J.</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wilson</surname>
              <given-names initials="M">Manda</given-names>
            </name>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Webber</surname>
              <given-names initials="AE">Amy E.</given-names>
            </name>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Yabe</surname>
              <given-names initials="M">Mariko</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Petrova-Drus</surname>
              <given-names initials="K">Kseniya</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rosenblum</surname>
              <given-names initials="M">Marc</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Durham</surname>
              <given-names initials="BH">Benjamin H.</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
            <xref rid="A9" ref-type="aff">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Abdel-Wahab</surname>
              <given-names initials="O">Omar</given-names>
            </name>
            <xref rid="A9" ref-type="aff">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Donoghue</surname>
              <given-names initials="MTA">Mark T.A.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kung</surname>
              <given-names initials="AL">Andrew L.</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Bender</surname>
              <given-names initials="JG">Julia Glade</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shukla</surname>
              <given-names initials="NN">Neerav N.</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Funt</surname>
              <given-names initials="SA">Samuel A.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dogan</surname>
              <given-names initials="A">Ahmet</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Soslow</surname>
              <given-names initials="RA">Robert A.</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Al-Ahmadie</surname>
              <given-names initials="H">Hikmat</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Feldman</surname>
              <given-names initials="DR">Darren R.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Van Allen</surname>
              <given-names initials="EM">Eliezer M.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Diamond</surname>
              <given-names initials="EL">Eli L.</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solit</surname>
              <given-names initials="DB">David B.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A9" ref-type="aff">9</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A2"><label>2</label>Department of Medical Oncology, Dana Farber Cancer Institute</aff>
        <aff id="A3"><label>3</label>Cancer Program, Broad Institute of MIT and Harvard</aff>
        <aff id="A4"><label>4</label>Department of Nursing, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A5"><label>5</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A6"><label>6</label>Department of Neurology, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A7"><label>7</label>Department of Pediatrics, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A8"><label>8</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A9"><label>9</label>Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A10"><label>10</label>Bioinformatics Core, Memorial Sloan Kettering Cancer Center, NY, New York, USA</aff>
        <aff id="A11"><label>11</label>Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel.</aff>
        <aff id="A12"><label>12</label>Adelson School of Medicine, Ariel University, Ariel, Israel</aff>
        <aff id="A13"><label>13</label>Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel</aff>
        <aff id="A14"><label>14</label>Translational Research Lab, Assuta Medical Center, Tel-Aviv, Israel.</aff>
        <aff id="A15"><label>15</label>Joan &amp; Sanford I. Weill Medical College of Cornell University, New York, NY, USA</aff>
        <aff id="A16"><label>16</label>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia</aff>
        <aff id="A17"><label>17</label>Harvard Graduate Program in Biophysics, Boston, MA, 02115, USA</aff>
        <aff id="A18"><label>18</label>Department of Internal Medicine, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain.</aff>
        <aff id="A19"><label>19</label>Department of Pathology, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain.</aff>
        <author-notes>
          <fn fn-type="con" id="FN1">
            <p id="P1"><bold>Author Contributions. Collection and assembly of data.</bold> Seyram Doe-Tetteh, Sabrina Camp, Jett Crowdis, Mark Donoghue, Anne Marie Noronha, Christina Bravo, Dalicia Reales, Hikmat Al- Ahmadie, Darren R. Feldman, Eliezer M. Van Allen, Eli L. Diamond, and David B. Solit. <bold>Data analysis and interpretation:</bold> Seyram Doe-Tetteh, Sabrina Camp, Jett Crowdis, Mark Donoghue, Anne Marie Noronha, Hikmat Al-Ahmadie, Darren R. Feldman, Eliezer M. Van Allen, Eli L. Diamond, and David B. Solit. <bold>Manuscript writing:</bold> All authors. <bold>Final approval of manuscript:</bold> All authors. <bold>Accountable for all aspects of the work:</bold> All authors.</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding Author:</bold> David B. Solit, MD, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, <email>solitd@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN2">
            <p id="P29"><bold>Competing Interests</bold>: Y.L. has received research funding from AstraZeneca, GSK, and REPARE Therapeutics unrelated to this work. C.A. has received consulting fees from Eisai, Merk, Roche/Genentech, Abbvie, AstraZeneca and Repare Therapeutics and clinical trial funding from AstraZeneca. M.Y. has served as a consultant for Janssen Research and Development. O.A.-W. has served as a consultant for H3B Biomedicine, Foundation Medicine Inc, Merck, and Janssen, Loxo Oncology/Lilly and is on the Scientific Advisory Board of Envisagenics Inc and Harmonic Discovery Inc.; O.A.-W. has received prior research funding from H3B Biomedicine, Loxo Oncology/Lilly, and Nurix Therapeutics unrelated to the current manuscript. M.B. has served as a consultant for Eli Lilly, PetDx and received research funding from Grail. J.G.B has served as a consultant for Jazz Pharmaceuticals, was an uncompensated consultant on a DSMB for Springworks, Merck and Pfizer and served on pediatric advisory boards for BMS and Eisai. She receives institutional research support (but no salary support) for clinical trials from Roche, Merck, Amgen, Lilly, BMS, Eisai, Novartis, Loxo-oncology, Cellectar and Bayer. S.A.F. has received research support from AstraZeneca, Genentech/Roche, and Decibel Therapeutics is a consultant/advisory board member for Merck and BioNTech, and owns stock in Urogen, Allogene Therapeutics, Neogene Therapeutics, Kronos Bio, ByHeart, 76Bio, Vida Ventures, Inconovir, and Doximity. A.D. served as a consultant for Incyte, EUSA Pharma, Loxo Oncology and receives research support from Roche and Takeda. R.A.S. was paid annually for serving as assistant editor for one of the USCAP society journals. H.A-A. has served as a consultant for AstraZeneca and Paige.AI. D.R.F. has received research funding from Telix Pharmaceuticals, Decibel Therapeutics, Astellas, Royalties from Up-to-Date, and has served as a consultant for BioNTech. E.M.V. has served as an advisor/Consultant to Tango Therapeutics, Genome Medical, Genomic Life, Enara Bio, Manifold Bio, Monte Rosa, Novartis Institute for Biomedical Research, Riva Therapeutics, Serinus Bio, has received research support from Novartis, BMS, Sanofi, and has equity interests in Tango Therapeutics, Genome Medical, Genomic Life, Syapse, Enara Bio, Manifold Bio, Microsoft, Monte Rosa, Riva Therapeutics, Serinus Bio. E.L.D. discloses unpaid editorial support from Pfizer, Inc, and paid advisory board membership with Day One Biopharmaceuticals and Springworks Therapeutics. D.B.S. has served as a consultant for/received honorarium from Pfizer, Loxo Oncology/Lilly, Vividion Therapeutics, Scorpion Therapeutics, FORE Therapeutics, Fog Pharma, Elsie Biotechnologies, and BridgeBio. The remaining authors declare no potential conflicts of interest.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>05</day>
          <month>7</month>
          <year>2023</year>
        </pub-date>
        <volume>29</volume>
        <issue>13</issue>
        <issue-id pub-id-type="pmc-issue-id">440315</issue-id>
        <fpage>2445</fpage>
        <lpage>2455</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>12</day>
              <month>04</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>05</day>
              <month>01</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>05</day>
              <month>01</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-15 13:25:13.573">
              <day>15</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1881288.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose.</title>
            <p id="P2">To overcome barriers to genomic testing for patients with rare cancers, we initiated a program to offer free clinical tumor genomic testing worldwide to patients with select rare cancer subtypes.</p>
          </sec>
          <sec id="S2">
            <title>Patients and Methods.</title>
            <p id="P3">Patients were recruited through social media outreach and engagement with disease-specific advocacy groups, with a focus on patients with histiocytosis, germ cell tumors, and pediatric cancers. Tumors were analyzed using the MSK-IMPACT next generation sequencing assay with the return of results to patients and their local physicians. Whole exome recapture was performed for female patients with germ cell tumors to define the genomic landscape of this rare cancer subtype.</p>
          </sec>
          <sec id="S3">
            <title>Results.</title>
            <p id="P4">333 patients were enrolled, and tumor tissue was received for 288 (86.4%), with 250 (86.8%) having tumor DNA of sufficient quality for MSK-IMPACT testing. Eighteen patients with histiocytosis have received genomically guided therapy to date, of whom 17 (94%) have had clinical benefit with a mean treatment duration of 21.7 months (range 6–40+). Whole exome sequencing of ovarian GCTs identified a subset with haploid genotypes, a phenotype rarely observed in other cancer types. Actionable genomic alterations were rare in ovarian GCT (28%), however, two patients with ovarian GCTs with squamous transformation had high tumor mutational burden, one of whom had a complete response to pembrolizumab.</p>
          </sec>
          <sec id="S4">
            <title>Conclusion.</title>
            <p id="P5">Direct-to-patient outreach can facilitate the assembly of cohorts of rare cancers of sufficient size to define their genomic landscape. By profiling tumors in a clinical laboratory, results could be reported to patients and their local physicians to guide treatment.</p>
          </sec>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
